|
15/08/2018 |
Evaluation of Biomodulin T® in patients with HIV/AIDS. Phase II/III. |
BIOCEN |
Registered outdated |
|
07/12/2016 |
NGcGM3/VSSP in small cell lung cancer |
CIM |
Registered outdated |
|
26/08/2013 |
ior ®EPOCIM as a cardioprotective agent in the surgery of rheumatic valvular disease. |
CIMAB |
Registered outdated |
|
05/11/2013 |
RituxCIM in relapsed or refractory indolent B-cell non-Hodgkin lymphoma |
CIM |
Registered outdated |
|
09/07/2020 |
Zinc-Children-Hospitalized-Pneumonia |
SAHUAPA |
Registered outdated |
|
09/07/2020 |
Second Line-Acute Asthma |
SAHUAPA |
Registered outdated |
|
28/04/2017 |
Safety and immunogenicity of VCN7-T in infants of 2 and 3 months. Phase I/II. |
FINLAY |
Registered outdated |
|
14/04/2020 |
ESPERANZA study |
CIGB |
Registered outdated |
|
12/11/2021 |
SOBERANA PLUS TURIN |
FINLAY |
Registered outdated |
|
15/12/2015 |
Vaxira as adjuvant treatment for non-small cell lung cancer |
CIM |
Registered outdated |
|
13/04/2020 |
CIGB 2020 in contacts and SARS-CoV-2 infection suspects |
CIGB |
Registered outdated |
|
04/12/2015 |
Dose scale-up and cohort expansion with the therapeutic mAb 14F7 |
CIM |
Registered outdated |
|
10/11/2021 |
Expanded Clinical Use of Nasalferon in COVID-19 |
CIGB |
Registered outdated |
|
01/09/2016 |
1B8 vs MabThera® in patients with Diffuse large B-cell lymphoma |
CIM |
Registered outdated |
|
05/01/2017 |
HEBERFERON in renal cell carcinoma |
CIGB |
Registered outdated |
|
03/02/2017 |
Phase I/II trial with the mutein no alfa of IL-2 |
CIM |
Registered outdated |
|
30/04/2017 |
CENTAURO-4 Study |
CIGB |
Registered outdated |
|
06/08/2020 |
Transfer factor in Chronic Kidney Disease |
CIGB |
Registered outdated |
|
13/10/2017 |
Community intrevention trial with VCN7-T in pediatric population, 2017-2021 (NeumoEfect) |
FINLAY |
Registered outdated |
|
14/08/2017 |
Biomodulin T Intramuscular for Thymus Hypoplasia in Children. Phase III |
BIOCEN |
Registered outdated |
